The Board of Directors of DaVita Inc. has authorized a buyback plan on April 30, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
147.1 USD | -0.01% | +6.19% | +40.44% |
May. 24 | FMC, Fresenius and Davita rise after Ozempic news | DP |
May. 15 | Truist Securities Raises Price Target on DaVita to $150 From $135, Keeps Hold Rating | MT |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
627,400 USD | +1.57% | +1.87% | 896B | ||
147.1 USD | -0.01% | +6.19% | 12.9B | ||
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+40.44% | 12.9B | |
+25.52% | 88.99B | |
-24.52% | 74.82B | |
-5.56% | 25.03B | |
+4.31% | 17.88B | |
-14.25% | 16.43B | |
+2.97% | 15.77B | |
+70.11% | 13.09B | |
+79.20% | 13.21B | |
+24.51% | 12.7B |
- Stock Market
- Equities
- DVA Stock
- News DaVita Inc.
- DaVita Inc. authorizes a Buyback Plan.